Technology | Vulnerable Financial Health
Action: SELL
Entry Target Zone:
$135.0 - $137.7
Target Discount: 6.6% below current price
Confidence: HIGH
Quant Score: 50/100. HOLD - Driven by massive valuation premium but strong balance sheet.
At $144.56, the stock is trading below its DCF Fair Value of $null (assumed growth: undefined), offering a null% margin of safety. ✅ Attractive entry point.
Over the last 3 years, Revenue grew at a CAGR of 10.48%, while Net Income changed by 26.19% annually. 📊 Solid tandem growth across both top and bottom lines.
Return on Invested Capital (ROIC) stands at 12.63%. ✅ Excellent capital allocation.
The balance sheet indicates a Distress (Danger) 🔴 with an Altman Z-Score of 1.7. Debt levels and liquidity are well-managed.
Executive Summary: Analyzed 5 relevant financial articles from the past 48 hours. Overall sentiment is Moderately Positive (6.5/10). News importance is Medium with moderately relevant coverage. 📈 Potential +1% to +3% upside.
Meaningful institutional ownership; monitor future filing changes for accumulation or distribution.
Low bearish positioning. Shorted shares decreased 11.1% versus the prior month. Days to cover is 1.77.
Reported insider selling: 12 sale(s) and no open-market purchases over 180 days.